04.18.22
Ovaterra by Fertility Nutraceuticals, a reproductive health company, announced the launch of two new prenatal vitamin supplements, Advanced Prenatal and Advanced Prep 35-39. They are prenatal capsules formulated with the full recommended daily value of choline for pregnant and nursing women, packaged in individual servings for on-the-go. Advanced Prep 35-39 includes 25mg of patented FERTINATAL, a micronized DHEA and is designed specifically for women aged 35-39, the more advanced reproductive age range.
The supplements were developed in collaboration with Rebecca Fett, author of It Starts with the Egg and Brain Health from Birth. Her background in molecular biology and biochemistry, as well as patent law, combined with her evidenced based research and her own fertility experience, was key in developing these unique prenatal vitamins, Ovaterra said.
“With her focus on evidence-based research and clinical studies, Rebecca has been an influential thought leader in our field for the last 5 years,” said Jodi Neuhauser, co-founder and CEO of Ovaterra. “Rebecca had been thinking about formulating her own line of supplements for a number of years, and we are honored that she chose to partner with us. Her evidence-based approach to supporting reproductive health is a perfect complement to what we do at Ovaterra. As a brand, we say quality is non-negotiable and knowledge is power – and we mean it. Guided by our team of scientists and medical professionals, and over 18 years of research, we are dedicated to developing the highest quality products and technology to help support women’s reproductive health.”
Ovaterra’s fertility supplements are designed to support the structure and function of sexual and reproductive organs and women’s health from preconception to menopause. The company utilizes FDA good manufacturing practices (GMPs) and uses ingredients in bioavailable forms.
Ovaterra’s new Advanced Prenatal supplements include 24 vitamins and minerals, and a daily dose is made up of six capsules, available in individual daily packs or in a four-week supply. The supplements are designed to be taken three months prior, during, and three months after pregnancy in order to support fertility, pregnancy, and postpartum health. Ovaterra’s scientific team is led by Dr. Norbert Gleicher MD, FACOG, FACS; Dr. David Barad MD, MS, FACOG; and Dr. Bruce Hollis PhD. Each product the company develops is done so alongside a researcher in the field.
The supplements were developed in collaboration with Rebecca Fett, author of It Starts with the Egg and Brain Health from Birth. Her background in molecular biology and biochemistry, as well as patent law, combined with her evidenced based research and her own fertility experience, was key in developing these unique prenatal vitamins, Ovaterra said.
“With her focus on evidence-based research and clinical studies, Rebecca has been an influential thought leader in our field for the last 5 years,” said Jodi Neuhauser, co-founder and CEO of Ovaterra. “Rebecca had been thinking about formulating her own line of supplements for a number of years, and we are honored that she chose to partner with us. Her evidence-based approach to supporting reproductive health is a perfect complement to what we do at Ovaterra. As a brand, we say quality is non-negotiable and knowledge is power – and we mean it. Guided by our team of scientists and medical professionals, and over 18 years of research, we are dedicated to developing the highest quality products and technology to help support women’s reproductive health.”
Ovaterra’s fertility supplements are designed to support the structure and function of sexual and reproductive organs and women’s health from preconception to menopause. The company utilizes FDA good manufacturing practices (GMPs) and uses ingredients in bioavailable forms.
Ovaterra’s new Advanced Prenatal supplements include 24 vitamins and minerals, and a daily dose is made up of six capsules, available in individual daily packs or in a four-week supply. The supplements are designed to be taken three months prior, during, and three months after pregnancy in order to support fertility, pregnancy, and postpartum health. Ovaterra’s scientific team is led by Dr. Norbert Gleicher MD, FACOG, FACS; Dr. David Barad MD, MS, FACOG; and Dr. Bruce Hollis PhD. Each product the company develops is done so alongside a researcher in the field.
